KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables (2016 - 2025)

Historic Receivables for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $2.4 billion.

  • Bausch Health Companies' Receivables rose 1542.5% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 1542.5%. This contributed to the annual value of $2.1 billion for FY2024, which is 710.71% up from last year.
  • As of Q3 2025, Bausch Health Companies' Receivables stood at $2.4 billion, which was up 1542.5% from $2.2 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Receivables registered a high of $2.4 billion during Q3 2025, and its lowest value of $1.5 billion during Q1 2021.
  • For the 5-year period, Bausch Health Companies' Receivables averaged around $1.9 billion, with its median value being $1.8 billion (2022).
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 1244.16% in 2021, then skyrocketed by 2132.7% in 2024.
  • Bausch Health Companies' Receivables (Quarter) stood at $1.8 billion in 2021, then rose by 0.85% to $1.8 billion in 2022, then rose by 11.62% to $2.0 billion in 2023, then rose by 7.11% to $2.1 billion in 2024, then increased by 12.94% to $2.4 billion in 2025.
  • Its Receivables was $2.4 billion in Q3 2025, compared to $2.2 billion in Q2 2025 and $2.1 billion in Q1 2025.